Transplant News and Research

RSS

Simultaneous face and hand transplant announced in the UK

Following the first full face transplant in the U.S., one of the leading surgeons in the U.K. has announced that he’s preparing to carry out a the world’s second simultaneous face and hand transplant.

23 Mar 2011

Australia’s first transplanted hand starts moving

Peter Walsh, 65, a grandfather, with no hands or feet has been wriggling his new fingers after becoming the first Australian recipient of a hand transplant. He underwent a landmark nine-hour operation at St Vincent's Hospital this week after years of painstaking planning by Melbourne specialists.

23 Mar 2011

NephRx receives new U.S. patent for NX002 to treat oral mucositis

NephRx Corporation today announced issuance of a new U.S. patent for its novel peptide NX002, which currently is in preclinical development for the treatment of oral mucositis.

23 Mar 2011

FDA approves Nordion's TheraSphere IDE for Phase III trial to treat HCC

Nordion Inc., a leading provider of products and services to the global health science market, today announced that it has received U.S. Food and Drug Administration approval to conduct a Phase III clinical trial for TheraSphere® under an Investigational Device Exemption.

23 Mar 2011

Study: Stem cell transplant may benefit patients with rapidly progressive MS

A long term study reports about the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous stem cell rescue for people with aggressive forms of multiple sclerosis.

22 Mar 2011

First full face transplant in the U.S. on its way to success

In a first of its kind, Dallas Wiens, a 25 year old construction worker who had suffered severe burns to his head two and a half years ago and lost his face, was given a new face by transplant. Until now he had a face void of features, except for a lipless mouth and a goatee beard. Even his eye sockets were smoothed over with skin taken from other parts of his body. This was after 22 surgical procedures.

21 Mar 2011

$CTI commences pixantrone PIX-R trial in relapsed/refractory diffuse large B-cell lymphoma$

CTI commences pixantrone PIX-R trial in relapsed/refractory diffuse large B-cell lymphoma

Cell Therapeutics, Inc. today announced that it has initiated its randomized pivotal trial of pixantrone for the treatment of relapsed/refractory diffuse large B-cell lymphoma ("DLBCL").

21 Mar 2011

Mayo Clinic, St. Andrew's Lighthouse announce opening of Gabriel House of Care

Mayo Clinic and St. Andrew's Lighthouse, Inc. will today announce the official opening of Gabriel House of Care at a dedication ceremony on the clinic's Jacksonville campus.

18 Mar 2011

U-M researcher endorses new concepts designed to improve kidney allocation

Providing kidney transplants to patients with the best probability of longer survival would reduce repeat transplant operations and improve life span after kidney transplant, says a U-M researcher in a commentary published in the New England Journal of Medicine March 16.

18 Mar 2011

Stem cell therapy successfully heals a scarred and failing heart

A new study has shown that stem cells could heal scars caused by old heart attacks. In all eight patients who received the experimental treatment in an ongoing clinical trial this therapy worked. All of them had suffered heart attacks an average of 5 1/2 years prior; one of the patients had his heart attack 11 years earlier.

17 Mar 2011

Beike, ThermoGenesis enter agreement to employ new technology for stem cell therapies

Beike Biotechnology Co. Ltd., China's leading stem cell research and regenerative medicine company, announced an agreement with USA-based ThermoGenesis Corp. to employ new, cutting edge stem cell processing and storage technology across its adult stem cell collection, processing, and archive platform.

17 Mar 2011

Ambry, LABS partner to offer new donor and patient screening options

LABS, Inc., the recognized leader in microbiology, infectious disease screening, cell/molecular biology and immunological testing for the transplant and biomedical sciences communities, today announced an agreement with Ambry Genetics, a global leader in molecular diagnostics and genomic services to the healthcare and life sciences industries, that will allow the organizations to provide superior testing services to a broader base of clients in the reproductive health industry.

16 Mar 2011

New study on how epoxyeicosatrienoic acids protect kidneys

Researchers at Georgia Health Sciences University are studying whether inhibiting an enzyme that reduces levels of a protective metabolite could halt the progression of diabetic nephropathy, or kidney disease resulting from diabetes.

16 Mar 2011

iTherX commences ITX-5061 Phase 1b study in patients with HCV

iTherX, a pharmaceutical company dedicated to discovering and developing a new class of therapies for hepatitis C, today announced that it has commenced patient recruitment in an open-label, proof-of-concept Phase 1b study of its lead compound ITX-5061 in liver transplant patients with hepatitis C virus infection.

16 Mar 2011

Incyte’s ruxolitinib COMFORT-II Phase III trial in MF meets primary endpoint

COMFORT-II, the second pivotal Phase III trial of Incyte Corporation's investigational Janus kinase inhibitor, ruxolitinib, has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis, when compared to best available therapy.

15 Mar 2011

Life Technologies receives FDA 510(k) clearance for StemPro MSC SFM device

Life Technologies Corporation today announced it has received FDA 510(k) clearance for StemPro MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States.

14 Mar 2011

New PTLD Guideline highlighted at NCCN Annual Conference

A new Guideline detailing diagnosis, workup, and treatment options for Post-Transplant Lymphoproliferative Disorder, as well as stronger recommendations for therapies in follicular lymphoma, topped the list of highlights in a presentation of the updated NCCN Guidelines for Non-Hodgkin's Lymphomas.

14 Mar 2011

New study identifies 15 genetic regions underlying primary biliary cirrhosis

Researchers have provided new clues into the genetics underlying a chronic form of liver disease, called primary biliary cirrhosis, which can lead to transplant surgery for patients.

14 Mar 2011

FMCNA encourages high blood pressure, diabetes people to learn about risk of CKD

Diabetes and high blood pressure are the two leading causes of chronic kidney disease, a health problem that is growing at an alarming rate in the United States. There are 26 million Americans who have CKD, and millions more are at increased risk and may not even know it.

11 Mar 2011

Texas Children's completes first phase of certification to implant SynCardia temporary Total Artificial Heart

Texas Children's Hospital and SynCardia Systems, Inc. announced today that Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The hospital intends to use the Total Artificial Heart as a bridge to transplant for their patients who received a heart transplant as children and now require mechanical support as a bridge to their second transplant.

11 Mar 2011